オーロラキナーゼBの世界市場（～2026年）

• 英文タイトル：Global Aurora Kinase B Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY02735 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はオーロラキナーゼBのグローバル市場について調査・分析したレポートです。種類別（AZD-2811、CS-2164、Danusertib、Ilorasertib、NMI-900、その他）市場規模、用途別（未分化大細胞リンパ腫、腎臓がん、肺がん、前立腺がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別オーロラキナーゼBの競争状況、市場シェア ・世界のオーロラキナーゼB市場：種類別市場規模 2015年-2020年（AZD-2811、CS-2164、Danusertib、Ilorasertib、NMI-900、その他） ・世界のオーロラキナーゼB市場：種類別市場規模予測 2021年-2026年（AZD-2811、CS-2164、Danusertib、Ilorasertib、NMI-900、その他） ・世界のオーロラキナーゼB市場：用途別市場規模 2015年-2020年（未分化大細胞リンパ腫、腎臓がん、肺がん、前立腺がん、その他） ・世界のオーロラキナーゼB市場：用途別市場規模予測 2021年-2026年（未分化大細胞リンパ腫、腎臓がん、肺がん、前立腺がん、その他） ・北米のオーロラキナーゼB市場分析：米国、カナダ ・ヨーロッパのオーロラキナーゼB市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのオーロラキナーゼB市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のオーロラキナーゼB市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのオーロラキナーゼB市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie Inc、Advenchen Laboratories LLC、Aeterna Zentaris Inc、Amgen Inc、AstraZeneca Plc、Chipscreen Biosciences Ltd、Cielo Therapeutics Inc、Sanofi、Sareum Holdings Plc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Aurora Kinase B Market
The global Aurora Kinase B market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Aurora Kinase B Scope and Market Size
Aurora Kinase B market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Aurora Kinase B market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Aurora Kinase B market is segmented into
AZD-2811
CS-2164
Danusertib
Ilorasertib
NMI-900
Others

Segment by Application, the Aurora Kinase B market is segmented into
Anaplastic Large Cell Lymphoma
Kidney Cancer
Lung Cancer
Prostate Cancer
Others

Regional and Country-level Analysis
The Aurora Kinase B market is analysed and market size information is provided by regions (countries).
The key regions covered in the Aurora Kinase B market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Aurora Kinase B Market Share Analysis
Aurora Kinase B market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Aurora Kinase B business, the date to enter into the Aurora Kinase B market, Aurora Kinase B product introduction, recent developments, etc.

The major vendors covered:
AbbVie Inc
Advenchen Laboratories LLC
Aeterna Zentaris Inc
Amgen Inc
AstraZeneca Plc
Chipscreen Biosciences Ltd
Cielo Therapeutics Inc
Sanofi
Sareum Holdings Plc

レポート目次

---

1 Study Coverage
1.1 Aurora Kinase B Product Introduction
1.2 Market Segments
1.3 Key Aurora Kinase B Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Aurora Kinase B Market Size Growth Rate by Type
1.4.2 AZD-2811
1.4.3 CS-2164
1.4.4 Danusertib
1.4.5 Ilorasertib
1.4.6 NMI-900
1.4.7 Others
1.5 Market by Application
1.5.1 Global Aurora Kinase B Market Size Growth Rate by Application
1.5.2 Anaplastic Large Cell Lymphoma
1.5.3 Kidney Cancer
1.5.4 Lung Cancer
1.5.5 Prostate Cancer
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Aurora Kinase B Market Size, Estimates and Forecasts
2.1.1 Global Aurora Kinase B Revenue 2015-2026
2.1.2 Global Aurora Kinase B Sales 2015-2026
2.2 Global Aurora Kinase B, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Aurora Kinase B Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Aurora Kinase B Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Aurora Kinase B Competitor Landscape by Players
3.1 Aurora Kinase B Sales by Manufacturers
3.1.1 Aurora Kinase B Sales by Manufacturers (2015-2020)
3.1.2 Aurora Kinase B Sales Market Share by Manufacturers (2015-2020)
3.2 Aurora Kinase B Revenue by Manufacturers
3.2.1 Aurora Kinase B Revenue by Manufacturers (2015-2020)
3.2.2 Aurora Kinase B Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Aurora Kinase B Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Aurora Kinase B Revenue in 2019
3.2.5 Global Aurora Kinase B Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Aurora Kinase B Price by Manufacturers
3.4 Aurora Kinase B Manufacturing Base Distribution, Product Types
3.4.1 Aurora Kinase B Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Aurora Kinase B Product Type
3.4.3 Date of International Manufacturers Enter into Aurora Kinase B Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Aurora Kinase B Market Size by Type (2015-2020)
4.1.1 Global Aurora Kinase B Sales by Type (2015-2020)
4.1.2 Global Aurora Kinase B Revenue by Type (2015-2020)
4.1.3 Aurora Kinase B Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Aurora Kinase B Market Size Forecast by Type (2021-2026)
4.2.1 Global Aurora Kinase B Sales Forecast by Type (2021-2026)
4.2.2 Global Aurora Kinase B Revenue Forecast by Type (2021-2026)
4.2.3 Aurora Kinase B Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Aurora Kinase B Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Aurora Kinase B Market Size by Application (2015-2020)
5.1.1 Global Aurora Kinase B Sales by Application (2015-2020)
5.1.2 Global Aurora Kinase B Revenue by Application (2015-2020)
5.1.3 Aurora Kinase B Price by Application (2015-2020)
5.2 Aurora Kinase B Market Size Forecast by Application (2021-2026)
5.2.1 Global Aurora Kinase B Sales Forecast by Application (2021-2026)
5.2.2 Global Aurora Kinase B Revenue Forecast by Application (2021-2026)
5.2.3 Global Aurora Kinase B Price Forecast by Application (2021-2026)

6 North America
6.1 North America Aurora Kinase B by Country
6.1.1 North America Aurora Kinase B Sales by Country
6.1.2 North America Aurora Kinase B Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Aurora Kinase B Market Facts & Figures by Type
6.3 North America Aurora Kinase B Market Facts & Figures by Application

7 Europe
7.1 Europe Aurora Kinase B by Country
7.1.1 Europe Aurora Kinase B Sales by Country
7.1.2 Europe Aurora Kinase B Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Aurora Kinase B Market Facts & Figures by Type
7.3 Europe Aurora Kinase B Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Aurora Kinase B by Region
8.1.1 Asia Pacific Aurora Kinase B Sales by Region
8.1.2 Asia Pacific Aurora Kinase B Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Aurora Kinase B Market Facts & Figures by Type
8.3 Asia Pacific Aurora Kinase B Market Facts & Figures by Application

9 Latin America
9.1 Latin America Aurora Kinase B by Country
9.1.1 Latin America Aurora Kinase B Sales by Country
9.1.2 Latin America Aurora Kinase B Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Aurora Kinase B Market Facts & Figures by Type
9.3 Central & South America Aurora Kinase B Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Aurora Kinase B by Country
10.1.1 Middle East and Africa Aurora Kinase B Sales by Country
10.1.2 Middle East and Africa Aurora Kinase B Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Aurora Kinase B Market Facts & Figures by Type
10.3 Middle East and Africa Aurora Kinase B Market Facts & Figures by Application

11 Company Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Corporation Information
11.1.2 AbbVie Inc Description and Business Overview
11.1.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Inc Aurora Kinase B Products Offered
11.1.5 AbbVie Inc Related Developments
11.2 Advenchen Laboratories LLC
11.2.1 Advenchen Laboratories LLC Corporation Information
11.2.2 Advenchen Laboratories LLC Description and Business Overview
11.2.3 Advenchen Laboratories LLC Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Advenchen Laboratories LLC Aurora Kinase B Products Offered
11.2.5 Advenchen Laboratories LLC Related Developments
11.3 Aeterna Zentaris Inc
11.3.1 Aeterna Zentaris Inc Corporation Information
11.3.2 Aeterna Zentaris Inc Description and Business Overview
11.3.3 Aeterna Zentaris Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Aeterna Zentaris Inc Aurora Kinase B Products Offered
11.3.5 Aeterna Zentaris Inc Related Developments
11.4 Amgen Inc
11.4.1 Amgen Inc Corporation Information
11.4.2 Amgen Inc Description and Business Overview
11.4.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Amgen Inc Aurora Kinase B Products Offered
11.4.5 Amgen Inc Related Developments
11.5 AstraZeneca Plc
11.5.1 AstraZeneca Plc Corporation Information
11.5.2 AstraZeneca Plc Description and Business Overview
11.5.3 AstraZeneca Plc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 AstraZeneca Plc Aurora Kinase B Products Offered
11.5.5 AstraZeneca Plc Related Developments
11.6 Chipscreen Biosciences Ltd
11.6.1 Chipscreen Biosciences Ltd Corporation Information
11.6.2 Chipscreen Biosciences Ltd Description and Business Overview
11.6.3 Chipscreen Biosciences Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Chipscreen Biosciences Ltd Aurora Kinase B Products Offered
11.6.5 Chipscreen Biosciences Ltd Related Developments
11.7 Cielo Therapeutics Inc
11.7.1 Cielo Therapeutics Inc Corporation Information
11.7.2 Cielo Therapeutics Inc Description and Business Overview
11.7.3 Cielo Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Cielo Therapeutics Inc Aurora Kinase B Products Offered
11.7.5 Cielo Therapeutics Inc Related Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Description and Business Overview
11.8.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi Aurora Kinase B Products Offered
11.8.5 Sanofi Related Developments
11.9 Sareum Holdings Plc
11.9.1 Sareum Holdings Plc Corporation Information
11.9.2 Sareum Holdings Plc Description and Business Overview
11.9.3 Sareum Holdings Plc Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Sareum Holdings Plc Aurora Kinase B Products Offered
11.9.5 Sareum Holdings Plc Related Developments
11.1 AbbVie Inc
11.1.1 AbbVie Inc Corporation Information
11.1.2 AbbVie Inc Description and Business Overview
11.1.3 AbbVie Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Inc Aurora Kinase B Products Offered
11.1.5 AbbVie Inc Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Aurora Kinase B Market Estimates and Projections by Region
12.1.1 Global Aurora Kinase B Sales Forecast by Regions 2021-2026
12.1.2 Global Aurora Kinase B Revenue Forecast by Regions 2021-2026
12.2 North America Aurora Kinase B Market Size Forecast (2021-2026)
12.2.1 North America: Aurora Kinase B Sales Forecast (2021-2026)
12.2.2 North America: Aurora Kinase B Revenue Forecast (2021-2026)
12.2.3 North America: Aurora Kinase B Market Size Forecast by Country (2021-2026)
12.3 Europe Aurora Kinase B Market Size Forecast (2021-2026)
12.3.1 Europe: Aurora Kinase B Sales Forecast (2021-2026)
12.3.2 Europe: Aurora Kinase B Revenue Forecast (2021-2026)
12.3.3 Europe: Aurora Kinase B Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Aurora Kinase B Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Aurora Kinase B Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Aurora Kinase B Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Aurora Kinase B Market Size Forecast by Region (2021-2026)
12.5 Latin America Aurora Kinase B Market Size Forecast (2021-2026)
12.5.1 Latin America: Aurora Kinase B Sales Forecast (2021-2026)
12.5.2 Latin America: Aurora Kinase B Revenue Forecast (2021-2026)
12.5.3 Latin America: Aurora Kinase B Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Aurora Kinase B Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Aurora Kinase B Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Aurora Kinase B Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Aurora Kinase B Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Aurora Kinase B Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Aurora Kinase B Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Aurora Kinase B Market Segments
Table 2. Ranking of Global Top Aurora Kinase B Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Aurora Kinase B Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AZD-2811
Table 5. Major Manufacturers of CS-2164
Table 6. Major Manufacturers of Danusertib
Table 7. Major Manufacturers of Ilorasertib
Table 8. Major Manufacturers of NMI-900
Table 9. Major Manufacturers of Others
Table 10. Global Aurora Kinase B Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Aurora Kinase B Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Aurora Kinase B Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Aurora Kinase B Sales Market Share by Regions (2015-2020)
Table 14. Global Aurora Kinase B Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Aurora Kinase B Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Aurora Kinase B Sales Share by Manufacturers (2015-2020)
Table 17. Global Aurora Kinase B Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Aurora Kinase B by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aurora Kinase B as of 2019)
Table 19. Aurora Kinase B Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Aurora Kinase B Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Aurora Kinase B Price (2015-2020) (USD/Pcs)
Table 22. Aurora Kinase B Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Aurora Kinase B Product Type
Table 24. Date of International Manufacturers Enter into Aurora Kinase B Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Aurora Kinase B Sales by Type (2015-2020) (K Pcs)
Table 27. Global Aurora Kinase B Sales Share by Type (2015-2020)
Table 28. Global Aurora Kinase B Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Aurora Kinase B Revenue Share by Type (2015-2020)
Table 30. Aurora Kinase B Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Aurora Kinase B Sales by Application (2015-2020) (K Pcs)
Table 32. Global Aurora Kinase B Sales Share by Application (2015-2020)
Table 33. North America Aurora Kinase B Sales by Country (2015-2020) (K Pcs)
Table 34. North America Aurora Kinase B Sales Market Share by Country (2015-2020)
Table 35. North America Aurora Kinase B Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Aurora Kinase B Revenue Market Share by Country (2015-2020)
Table 37. North America Aurora Kinase B Sales by Type (2015-2020) (K Pcs)
Table 38. North America Aurora Kinase B Sales Market Share by Type (2015-2020)
Table 39. North America Aurora Kinase B Sales by Application (2015-2020) (K Pcs)
Table 40. North America Aurora Kinase B Sales Market Share by Application (2015-2020)
Table 41. Europe Aurora Kinase B Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Aurora Kinase B Sales Market Share by Country (2015-2020)
Table 43. Europe Aurora Kinase B Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Aurora Kinase B Revenue Market Share by Country (2015-2020)
Table 45. Europe Aurora Kinase B Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Aurora Kinase B Sales Market Share by Type (2015-2020)
Table 47. Europe Aurora Kinase B Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Aurora Kinase B Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Aurora Kinase B Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Aurora Kinase B Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Aurora Kinase B Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Aurora Kinase B Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Aurora Kinase B Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Aurora Kinase B Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Aurora Kinase B Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Aurora Kinase B Sales Market Share by Application (2015-2020)
Table 57. Latin America Aurora Kinase B Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Aurora Kinase B Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Aurora Kinase B Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Aurora Kinase B Revenue Market Share by Country (2015-2020)
Table 61. Latin America Aurora Kinase B Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Aurora Kinase B Sales Market Share by Type (2015-2020)
Table 63. Latin America Aurora Kinase B Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Aurora Kinase B Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Aurora Kinase B Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Aurora Kinase B Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Aurora Kinase B Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Aurora Kinase B Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Aurora Kinase B Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Aurora Kinase B Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Aurora Kinase B Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Aurora Kinase B Sales Market Share by Application (2015-2020)
Table 73. AbbVie Inc Corporation Information
Table 74. AbbVie Inc Description and Major Businesses
Table 75. AbbVie Inc Aurora Kinase B Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. AbbVie Inc Product
Table 77. AbbVie Inc Recent Development
Table 78. Advenchen Laboratories LLC Corporation Information
Table 79. Advenchen Laboratories LLC Description and Major Businesses
Table 80. Advenchen Laboratories LLC Aurora Kinase B Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Advenchen Laboratories LLC Product
Table 82. Advenchen Laboratories LLC Recent Development
Table 83. Aeterna Zentaris Inc Corporation Information
Table 84. Aeterna Zentaris Inc Description and Major Businesses
Table 85. Aeterna Zentaris Inc Aurora Kinase B Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Aeterna Zentaris Inc Product
Table 87. Aeterna Zentaris Inc Recent Development
Table 88. Amgen Inc Corporation Information
Table 89. Amgen Inc Description and Major Businesses
Table 90. Amgen Inc Aurora Kinase B Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Amgen Inc Product
Table 92. Amgen Inc Recent Development
Table 93. AstraZeneca Plc Corporation Information
Table 94. AstraZeneca Plc Description and Major Businesses
Table 95. AstraZeneca Plc Aurora Kinase B Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. AstraZeneca Plc Product
Table 97. AstraZeneca Plc Recent Development
Table 98. Chipscreen Biosciences Ltd Corporation Information
Table 99. Chipscreen Biosciences Ltd Description and Major Businesses
Table 100. Chipscreen Biosciences Ltd Aurora Kinase B Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Chipscreen Biosciences Ltd Product
Table 102. Chipscreen Biosciences Ltd Recent Development
Table 103. Cielo Therapeutics Inc Corporation Information
Table 104. Cielo Therapeutics Inc Description and Major Businesses
Table 105. Cielo Therapeutics Inc Aurora Kinase B Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Cielo Therapeutics Inc Product
Table 107. Cielo Therapeutics Inc Recent Development
Table 108. Sanofi Corporation Information
Table 109. Sanofi Description and Major Businesses
Table 110. Sanofi Aurora Kinase B Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Sanofi Product
Table 112. Sanofi Recent Development
Table 113. Sareum Holdings Plc Corporation Information
Table 114. Sareum Holdings Plc Description and Major Businesses
Table 115. Sareum Holdings Plc Aurora Kinase B Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Sareum Holdings Plc Product
Table 117. Sareum Holdings Plc Recent Development
Table 118. Global Aurora Kinase B Sales Forecast by Regions (2021-2026) (K Pcs)
Table 119. Global Aurora Kinase B Sales Market Share Forecast by Regions (2021-2026)
Table 120. Global Aurora Kinase B Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 121. Global Aurora Kinase B Revenue Market Share Forecast by Regions (2021-2026)
Table 122. North America: Aurora Kinase B Sales Forecast by Country (2021-2026) (K Pcs)
Table 123. North America: Aurora Kinase B Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Europe: Aurora Kinase B Sales Forecast by Country (2021-2026) (K Pcs)
Table 125. Europe: Aurora Kinase B Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Asia Pacific: Aurora Kinase B Sales Forecast by Region (2021-2026) (K Pcs)
Table 127. Asia Pacific: Aurora Kinase B Revenue Forecast by Region (2021-2026) (US$ Million)
Table 128. Latin America: Aurora Kinase B Sales Forecast by Country (2021-2026) (K Pcs)
Table 129. Latin America: Aurora Kinase B Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Middle East and Africa: Aurora Kinase B Sales Forecast by Country (2021-2026) (K Pcs)
Table 131. Middle East and Africa: Aurora Kinase B Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 133. Key Challenges
Table 134. Market Risks
Table 135. Main Points Interviewed from Key Aurora Kinase B Players
Table 136. Aurora Kinase B Customers List
Table 137. Aurora Kinase B Distributors List
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Aurora Kinase B Product Picture
Figure 2. Global Aurora Kinase B Sales Market Share by Type in 2020 & 2026
Figure 3. AZD-2811 Product Picture
Figure 4. CS-2164 Product Picture
Figure 5. Danusertib Product Picture
Figure 6. Ilorasertib Product Picture
Figure 7. NMI-900 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Aurora Kinase B Sales Market Share by Application in 2020 & 2026
Figure 10. Anaplastic Large Cell Lymphoma
Figure 11. Kidney Cancer
Figure 12. Lung Cancer
Figure 13. Prostate Cancer
Figure 14. Others
Figure 15. Aurora Kinase B Report Years Considered
Figure 16. Global Aurora Kinase B Market Size 2015-2026 (US$ Million)
Figure 17. Global Aurora Kinase B Sales 2015-2026 (K Pcs)
Figure 18. Global Aurora Kinase B Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Aurora Kinase B Sales Market Share by Region (2015-2020)
Figure 20. Global Aurora Kinase B Sales Market Share by Region in 2019
Figure 21. Global Aurora Kinase B Revenue Market Share by Region (2015-2020)
Figure 22. Global Aurora Kinase B Revenue Market Share by Region in 2019
Figure 23. Global Aurora Kinase B Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Aurora Kinase B Revenue in 2019
Figure 25. Aurora Kinase B Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Aurora Kinase B Sales Market Share by Type (2015-2020)
Figure 27. Global Aurora Kinase B Sales Market Share by Type in 2019
Figure 28. Global Aurora Kinase B Revenue Market Share by Type (2015-2020)
Figure 29. Global Aurora Kinase B Revenue Market Share by Type in 2019
Figure 30. Global Aurora Kinase B Market Share by Price Range (2015-2020)
Figure 31. Global Aurora Kinase B Sales Market Share by Application (2015-2020)
Figure 32. Global Aurora Kinase B Sales Market Share by Application in 2019
Figure 33. Global Aurora Kinase B Revenue Market Share by Application (2015-2020)
Figure 34. Global Aurora Kinase B Revenue Market Share by Application in 2019
Figure 35. North America Aurora Kinase B Sales Growth Rate 2015-2020 (K Pcs)
Figure 36. North America Aurora Kinase B Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Aurora Kinase B Sales Market Share by Country in 2019
Figure 38. North America Aurora Kinase B Revenue Market Share by Country in 2019
Figure 39. U.S. Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. U.S. Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 42. Canada Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Aurora Kinase B Market Share by Type in 2019
Figure 44. North America Aurora Kinase B Market Share by Application in 2019
Figure 45. Europe Aurora Kinase B Sales Growth Rate 2015-2020 (K Pcs)
Figure 46. Europe Aurora Kinase B Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Aurora Kinase B Sales Market Share by Country in 2019
Figure 48. Europe Aurora Kinase B Revenue Market Share by Country in 2019
Figure 49. Germany Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Germany Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. France Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. U.K. Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Italy Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Aurora Kinase B Market Share by Type in 2019
Figure 60. Europe Aurora Kinase B Market Share by Application in 2019
Figure 61. Asia Pacific Aurora Kinase B Sales Growth Rate 2015-2020 (K Pcs)
Figure 62. Asia Pacific Aurora Kinase B Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Aurora Kinase B Sales Market Share by Region in 2019
Figure 64. Asia Pacific Aurora Kinase B Revenue Market Share by Region in 2019
Figure 65. China Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. China Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. South Korea Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. India Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Australia Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Taiwan Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Indonesia Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Thailand Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Malaysia Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Philippines Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Vietnam Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific Aurora Kinase B Market Share by Type in 2019
Figure 88. Asia Pacific Aurora Kinase B Market Share by Application in 2019
Figure 89. Latin America Aurora Kinase B Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America Aurora Kinase B Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Aurora Kinase B Sales Market Share by Country in 2019
Figure 92. Latin America Aurora Kinase B Revenue Market Share by Country in 2019
Figure 93. Mexico Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Brazil Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Argentina Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America Aurora Kinase B Market Share by Type in 2019
Figure 100. Latin America Aurora Kinase B Market Share by Application in 2019
Figure 101. Middle East and Africa Aurora Kinase B Sales Growth Rate 2015-2020 (K Pcs)
Figure 102. Middle East and Africa Aurora Kinase B Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa Aurora Kinase B Sales Market Share by Country in 2019
Figure 104. Middle East and Africa Aurora Kinase B Revenue Market Share by Country in 2019
Figure 105. Turkey Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Turkey Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. Saudi Arabia Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E Aurora Kinase B Sales Growth Rate (2015-2020) (K Pcs)
Figure 110. U.A.E Aurora Kinase B Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa Aurora Kinase B Market Share by Type in 2019
Figure 112. Middle East and Africa Aurora Kinase B Market Share by Application in 2019
Figure 113. North America Aurora Kinase B Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. North America Aurora Kinase B Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Aurora Kinase B Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Europe Aurora Kinase B Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Aurora Kinase B Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Asia Pacific Aurora Kinase B Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Aurora Kinase B Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Latin America Aurora Kinase B Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Aurora Kinase B Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 122. Middle East and Africa Aurora Kinase B Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed

---